Chief Medical Officer · AVEO PHARMACEUTICALS, INC. (AVEO)

Michael Needle

A named executive officer of AVEO PHARMACEUTICALS in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,407,276

Salary $416,409Stock awards $0

FY2020: $830,071

2nd of 4 named executive officers at Aveo Pharmaceuticals by FY2021 total.

4 named officers on file for AVEO PHARMACEUTICALS, FY2021

Michael Needle’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • AVEO’s disclosed peer group of 13 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how AVEO PHARMACEUTICALS’s whole pay program stands against its peers

  • AVEO PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AVEO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2022 (DEF 14A).

Free

Get Michael Needle’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Michael Needle compensation by year

AVEO PHARMACEUTICALS Summary Compensation Table · all 2 fiscal years held
In US dollars, as AVEO PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$451,858$416,409
Bonus$0$0
Stock awards$0$0
Option awards$129,960$718,570
Non-equity incentive$235,978$0
Pension and deferred compensation$0$0
All other$12,275$272,297
Total$830,071$1,407,276

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AVEO PHARMACEUTICALS, INC. DEF 14A filed April 26, 2022, accession 0001628280-22-010614, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AVEO PHARMACEUTICALS, INC. filed document, accession 0001628280-22-010614. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2022.

$830K
$1.4M
FY20
FY21
SalaryNon-equity incentiveOption awardsAll other

AVEO PHARMACEUTICALS’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Michael BaileyChief Executive Officer$2,943,905
Michael Needle · this pageChief Medical Officer$1,407,276
Michael FerraressoChief Commercial Officer$1,250,121
Erick LuceraChief Financial Officer$1,242,784

The full AVEO PHARMACEUTICALS compensation record

free company brief

This page is one person within AVEO PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AVEO PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Needle's compensation dossier · One-time report. No refunds.